{"article_title": "Cancer Drugs Among Those Most Affected by Medicare Drug Payment Proposal", "article_keywords": ["physicians", "lower", "affected", "cancer", "vice", "drugs", "prescribe", "drug", "cost", "medicare", "treat", "statement", "avalere", "proposal", "payment"], "article_url": "https://morningconsult.com/alert/cancer-drugs-among-affected-medicare-drug-payment-proposal/", "article_text": "Proposed changes to how Medicare reimburses health care providers for prescription drugs would lower reimbursements for drugs that cost more than $480 per day, meaning physicians who treat cancers and other diseases would see greater reductions, an analysis released today from Avalere Health finds.\n\nSpecialists who use higher cost drugs, such as ophthalmologists, oncologists, and rheumatologists, would experience reduced payments, while physicians who tend to prescribe lower-cost drugs would be paid more, the report says. Additionally, seven of the 10 drugs that would constitute the largest reductions are used to treat cancers, it finds.\n\n\u201cWe have found that $480 is the tipping point for how Part B drug reimbursement would change under this new rule,\u201d Adam Borden, vice president at Avalere, said in a statement. \u201cPhysicians who prescribe drugs that cost more would receive lower Medicare payments.\u201d\n\nWhile a majority of the 10 most-affected drugs treat cancer, Avalere finds ophthalmologists would be most affected by the change, though oncologists and rheumatologists would also receive lower Medicare reimbursements.\n\nIn many cases, physicians don\u2019t have the option to prescribe a less expensive alternative, said Fauzea Hussain, senior vice president at Avalere.\n\n\u201cThe proposed Part B payment changes would redistribute funding from some specialists who use newer, more expensive drugs to care for their patients,\u201d she said in a statement. \u201cIn many cases, there are no lower-cost, clinically meaningful alternatives available for these conditions.\u201d", "article_metadata": {"msapplication-config": "/icons/browserconfig.xml", "og": {"site_name": "Morning Consult", "description": "Proposed changes to how Medicare reimburses health care providers for prescription drugs would lower reimbursements for drugs that cost more than $480 per day, meaning physicians who\u00a0treat cancers and other diseases would see greater reductions, an analysis released today from Avalere Health finds. Specialists\u00a0who use higher cost drugs, such as ophthalmologists, oncologists, and rheumatologists, would... read more", "title": "Cancer Drugs Among Those Most Affected by Medicare Drug Payment Proposal - Morning Consult", "locale": "en_US", "image": "https://morningconsult.com/wp-content/themes/morning-consult/img/MC_logo_twitter_fb.png", "url": "https://morningconsult.com/alert/cancer-drugs-among-affected-medicare-drug-payment-proposal/", "type": "article"}, "twitter": {"description": "Proposed changes to how Medicare reimburses health care providers for prescription drugs would lower reimbursements for drugs that cost more than $480 per day, meaning physicians who\u00a0treat cancers and other diseases would see greater reductions, an analysis released today from Avalere Health finds. Specialists\u00a0who use higher cost drugs, such as ophthalmologists, oncologists, and rheumatologists, would... read more", "title": "Cancer Drugs Among Those Most Affected by Medicare Drug Payment Proposal - Morning Consult", "image": "https://morningconsult.com/wp-content/themes/morning-consult/img/MC_logo_twitter_fb.png", "creator": "@melmcintire", "site": "@morningconsult", "card": "summary"}, "msapplication-TileColor": "#2b5797", "theme-color": "#ffffff", "msapplication-TileImage": "/icons/mstile-144x144.png", "article": {"publisher": "https://www.facebook.com/Morning-Consult-183517831660100/", "section": "Health"}, "viewport": "width=device-width, initial-scale=1"}, "article_summary": "\u201cPhysicians who prescribe drugs that cost more would receive lower Medicare payments.\u201dWhile a majority of the 10 most-affected drugs treat cancer, Avalere finds ophthalmologists would be most affected by the change, though oncologists and rheumatologists would also receive lower Medicare reimbursements.\nSpecialists who use higher cost drugs, such as ophthalmologists, oncologists, and rheumatologists, would experience reduced payments, while physicians who tend to prescribe lower-cost drugs would be paid more, the report says.\nAdditionally, seven of the 10 drugs that would constitute the largest reductions are used to treat cancers, it finds.\nIn many cases, physicians don\u2019t have the option to prescribe a less expensive alternative, said Fauzea Hussain, senior vice president at Avalere.\n\u201cThe proposed Part B payment changes would redistribute funding from some specialists who use newer, more expensive drugs to care for their patients,\u201d she said in a statement."}